A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial

Dominick J. Angiolillo, Mark B. Effron, Jorge F. Saucedo et al.|European Heart Journal|2011

Cited by 182